Not applicableUnknownNCT00977509What this trial is testingGene Mutations in Non-Small Cell Lung Cancer CellsWho this might be right forCarcinoma, Non-Small-Cell Lung National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT07130032What this trial is testingEfficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeWho this might be right forMetastatic Non-small Cell Lung Cancer (NSCLC)Metastatic Cutaneous Melanoma EuroCityClinic LLC 90
Testing effectiveness (Phase 2)Study completedNCT01941316What this trial is testingStudy of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer PatientsWho this might be right forSmall Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers Cancer Research and Biostatistics Clinical Trials Consortium 78
Early research (Phase 1)Ended earlyNCT02919449What this trial is testingDose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With AtezolizumabWho this might be right forRecurrent Non-Small Cell Lung Cancer Vyriad, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT00055978What this trial is testingCelecoxib in Preventing Lung Cancer in Former Heavy SmokersWho this might be right forLung Cancer University of California, Los Angeles 112
Not applicableStudy completedNCT07827885What this trial is testing20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLCWho this might be right forNon-Small Cell Lung Cancer Fondazione Policlinico Universitario Campus Bio-Medico 80
Testing effectiveness (Phase 2)Looking for participantsNCT06780085What this trial is testingInvestigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)Who this might be right forCarcinoma, Non-Small-Cell Lung Merck Sharp & Dohme LLC 96
Testing effectiveness (Phase 2)Looking for participantsNCT06567015What this trial is testingStudy of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIsWho this might be right forNon-small Cell Lung Cancer (NSCLC) Pierre Fabre Medicament 171
Testing effectiveness (Phase 2)Ended earlyNCT05500508What this trial is testingOral AMXT 1501 Dicaprate in Combination With IV DFMOWho this might be right forCancerSolid TumorSolid Carcinoma+17 more Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00890825What this trial is testingAZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC PatientsWho this might be right forNon Small Cell Lung Cancer AstraZeneca 88
Testing effectiveness (Phase 2)Study completedNCT00326599What this trial is testingGemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 101
Large-scale testing (Phase 3)Not Yet RecruitingNCT07361484What this trial is testingDocetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)Who this might be right forNon-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cance BeyondSpring Pharmaceuticals Inc. 442
Large-scale testing (Phase 3)Looking for participantsNCT06881784What this trial is testingStudy of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)Who this might be right forNSCLC (Non-small Cell Lung Cancer)Non-Small Cell Lung CancerNSCLC+2 more Revolution Medicines, Inc. 590
Testing effectiveness (Phase 2)Study completedNCT01853878What this trial is testingDemonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their TumorWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 137
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132What this trial is testingStudy of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)Who this might be right forSolid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more EMD Serono Research & Development Institute, Inc. 184
Testing effectiveness (Phase 2)Ended earlyNCT00281021What this trial is testingSecond Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small Cell Lung University of Louisville 26
Early research (Phase 1)Study completedNCT07504484What this trial is testingSafety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung CancerWho this might be right forCRC (Colorectal Cancer)Non Small Lung Cancer Ying Yuan, MD 6
Not applicableStudy completedNCT01687738What this trial is testingLung Cancer Surgery: Decisions Against Life Saving Care - The InterventionWho this might be right forNon-small Cell Lung Cancer University of North Carolina, Chapel Hill 238
Early research (Phase 1)Not Yet RecruitingNCT06743555What this trial is testingSurgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot StudyWho this might be right forNon-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy+2 more Centre hospitalier de l'Université de Montréal (CHUM) 14
Early research (Phase 1)Study completedNCT04052971What this trial is testingTo Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET DysregulationWho this might be right forAdvanced Solid Tumors Abion Inc 24